CPIX - CIK 0001087294
CUMBERLAND PHARMACEUTICALS INC (CPIX) reported revenue of $44.52M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $44.52M | +17.6% |
| FY 2024 | $37.87M | -4.3% |
| FY 2023 | $39.55M | -5.9% |
| FY 2022 | $42.01M | +16.7% |
| FY 2021 | $35.99M | -3.9% |
| FY 2020 | $37.44M | +8.9% |
| FY 2019 | $34.39M | +17.2% |
| FY 2018 | $29.34M | +11.5% |
| FY 2017 |
CUMBERLAND PHARMACEUTICALS INC (CPIX) reported revenue of $44.52M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CUMBERLAND PHARMACEUTICALS INC's revenue declined from $51.14M to $44.52M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $26.32M |
| -20.3% |
| FY 2016 | $33.03M | +3569.5% |
| FY 2015 | $900.00K | +50.0% |
| FY 2014 | $600.00K | -25.0% |
| FY 2013 | $800.00K | +14.3% |
| FY 2012 | $700.00K | -98.6% |
| FY 2011 | $51.14M | - |